p16INK4a Status and Response to Induction Low-Dose Fractionated Radiation in Advanced Head and Neck Cancer

Abstract

Objective:

To evaluate the impact of p16INK4a (p16) expression on clinical efficacy of induction low-dose fractionated radiation therapy (LDFRT) with concurrent chemotherapy in patients with locally advanced squamous cell carcinoma of the head and neck (SCCHN).

Study Design:

Historical cohort study.

Setting:

Tertiary medical center.

Methods:

A total of 66 Patients with locally advanced SCCHN were enrolled in 2 clinical trials using paclitaxel, carboplatin, and concurrent LDFRT induction therapy. Patients were evaluated for response to induction by a multidisciplinary team and then were given definitive treatment. Adequate tissue samples from the pretreatment biopsies of 42 individuals were identified and analyzed for p16 expression. Expression was correlated with clinical outcomes.

Results:

Of 42 tumors, 15 (35.7%) were positive for p16. Patients with p16-positive tumors had improved response to induction, but this was not statistically significant (P = .06). Five-year overall survival was 80% in p16-positive patients and 58% in p16-negative patients (P = .025).

Conclusions:

p16 Expression affects treatment response in patients treated with induction LDFRT with concurrent chemotherapy. This is similar to results reported for standard induction chemotherapy.

Keywords

low-dose radiotherapy chemotherapy induction head and neck squamous cell carcinoma p16 human papillomavirus

Get full access to this article

View all access options for this article.

References

Gillison

Shah

. Human papillomavirus-associated head and neck squamous cell carcinoma: mounting evidence for an etiologic role for human papillomavirus in a subset of head and neck cancers. Curr Opin Oncol. 2001;13:183-188.

Licitra

Perrone

Bossi

. High-risk human papillomavirus affects prognosis in patients with surgically treated oropharyngeal squamous cell carcinoma. J Clin Oncol. 2006;24:5630-5636.

Mellin

Friesland

Lewensohn

Dalianis

Munck-Wikland

. Human papillomavirus (HPV) DNA in tonsillar cancer: clinical correlates, risk of relapse, and survival. Int J Cancer. 2000;89:300-304.

Lindel

Beer

Laissue

Greiner

Aebersold

. Human papillomavirus positive squamous cell carcinoma of the oropharynx: a radiosensitive subgroup of head and neck carcinoma. Cancer. 2001;92:805-813.

Kumar

Cordell

Lee

. EGFR, p16, HPV Titer, Bcl-xL and p53, sex, and smoking as indicators of response to therapy and survival in oropharyngeal cancer. J Clin Oncol. 2008;26:3128-3137.

Arnold

Regine

Ahmed

. Low-dose fractionated radiation as a chemopotentiator of neoadjuvant paclitaxel and carboplatin for locally advanced squamous cell carcinoma of the head and neck: results of a new treatment paradigm. Int J Radiat Biol. 2004;58:1411-1417.

Gleason

Kudrimoti

VanMeter

. Low-dose fractionated radiation with induction chemotherapy for locally advanced squamous cell carcinoma of the head and neck: 5 year results of a prospective phase II trial. Int J Radiat Oncol Biol Phys. In press.

Joiner

Marples

. Does induced repair determine the lethal effects of very low radiation doses? Br J Radiol. 1992;24:74-78.

Joiner

Lambin

Malaise

. Hypersensitivity to very-low single radiation doses: its relationship to the adaptive response and induced radioresistance. Mutat Res. 1996;358:171-183.

10.

Marples

Collis

. Low-dose hyper-radiosensitivity: past, present, and future. Int J Radiat Biol. 2008;70:1310-1318.

11.

Gupta

Koru-Sengul

Arnold

Devi

Mohiuddin

Ahmed

. Low-dose fractionated radiation potentiates the effects of cisplatin independent of the hyper-radiation sensitivity in human lung cancer cells. Mol Cancer Ther. 2011;10:292-302.

12.

Chendil

Oakes

Alcock

. Low dose fractionated radiation enhances the radiosensitization effect of paclitaxel in colorectal tumor cells with mutant p53. Cancer. 2000;89:1893-1900.

13.

Dey

Spring

Arnold

. Low-dose fractionated radiation potentiates the effects of paclitaxel in wild-type and mutant p53 head and neck tumor cell lines. Clin Cancer Res. 2003;9:1557-1565.

14.

Spring

Arnold

Shajahan

. Low dose fractionated radiation potentiates the effects of taxotere in nude mice xenografts of squamous cell carcinoma of head and neck. Cell Cycle. 2004;3:479-485.

15.

Fakhry

Westra

. Improved survival of patients with human papillomavirus-positive head and neck squamous cell carcinoma in a prospective clinical trial. J Natl Cancer Inst. 2008;100:261-269.

16.

Perrone

Gloghini

Cortelazzi

Bossi

Licitra

Pilotti

. Isolating p16-positive/HPV-negative oropharyngeal cancer: an effort worth making. Am J Surg Pathol. 2011;35:774-777; author reply 777-778.

17.

Granata

Miceli

Orlandi

. Tumor stage, human papillomavirus and smoking status affect the survival of patients with oropharyngeal cancer: an Italian validation study. Ann Oncol. 2012;23:1832-1837.

18.

Posner

Lorch

Goloubeva

. Survival and human papillomavirus in oropharynx cancer in TAX 324: a subset analysis from an international phase III trial. Ann Oncol. 2011;22:1071-1077.

19.

Isayeva

Maswahu

Brandwein-Gensler

. Human papillomavirus in non-oropharyngeal head and neck cancers: a systematic literature review. Head Neck Pathol. 2012;6(suppl 1):S104-S120.

20.

Chung

Zhang

Kong

. p16 Protein expression and human papillomavirus status as prognostic biomarkers of nonoropharyngeal head and neck squamous cell carcinoma. J Clin Oncol. 2014;32:3930-3938.

21.

Zorat

Paccagnella

Cavaniglia

. Randomized phase III trial of neoadjuvant chemotherapy in head and neck cancer: 10-year follow-up. J Natl Cancer Inst. 2004;96:1714-1717.

22.

Posner

Vermorken

. Induction therapy in the modern era of combined-modality therapy for locally advanced head and neck cancer. Semin Oncol. 2008;35:221-228.